黏膜皮肤不良反应与口腔西罗莫司治疗血管畸形相关。
Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.
机构信息
Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.
Vascular Anomalies Center, Boston Children's Hospital, Boston, Massachusetts.
出版信息
JAMA Dermatol. 2021 Feb 1;157(2):233-235. doi: 10.1001/jamadermatol.2020.5180.
Abstract
This case series examines the clinical spectrum and frequency of mucocutaneous adverse events related to oral sirolimus in populations with vascular anomalies.
摘要
本病例系列研究了血管异常人群中与口服西罗莫司相关的黏膜皮肤不良事件的临床谱和频率。
相似文献
1
Mucocutaneous Adverse Events Associated With Oral Sirolimus for the Treatment of Vascular Anomalies.黏膜皮肤不良反应与口腔西罗莫司治疗血管畸形相关。
JAMA Dermatol. 2021 Feb 1;157(2):233-235. doi: 10.1001/jamadermatol.2020.5180.
2
Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.西罗莫司用于治疗复杂血管异常——一种针对极低龄婴儿的拟用给药方案。
Int J Pediatr Otorhinolaryngol. 2018 Feb;105:48-51. doi: 10.1016/j.ijporl.2017.11.034. Epub 2017 Dec 1.
3
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations.亚洲血管畸形儿童使用西罗莫司的真实世界数据。
Paediatr Drugs. 2024 May;26(3):309-317. doi: 10.1007/s40272-023-00605-7. Epub 2024 Jan 27.
4
Topical sirolimus for the treatment of cutaneous manifestations of vascular anomalies: A case series.局部应用西罗莫司治疗血管异常的皮肤表现：病例系列。
Pediatr Blood Cancer. 2020 Apr;67(4):e28088. doi: 10.1002/pbc.28088. Epub 2020 Jan 13.
5
Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.局部应用西罗莫司治疗表浅血管异常：多中心病例系列。
Pediatr Dermatol. 2020 Mar;37(2):272-277. doi: 10.1111/pde.14104. Epub 2020 Jan 19.
6
Sirolimus for the treatment of complicated vascular anomalies in children.西罗莫司治疗儿童复杂血管畸形。
Pediatr Blood Cancer. 2011 Dec 1;57(6):1018-24. doi: 10.1002/pbc.23124. Epub 2011 Mar 28.
7
Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.口腔和局部用西罗莫司治疗血管异常：一项多中心研究和综述。
Acta Derm Venereol. 2019 Oct 1;99(11):990-996. doi: 10.2340/00015555-3262.
8
Mucocutaneous disorders in renal transplant recipients receiving sirolimus-based immunosuppressive therapy: a prospective, case-control study.接受西罗莫司为基础的免疫抑制治疗的肾移植受者的黏膜皮肤疾病：一项前瞻性、病例对照研究。
Clin Transplant. 2013 Sep-Oct;27(5):742-8. doi: 10.1111/ctr.12215. Epub 2013 Aug 31.
9
Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy.接受西罗莫司治疗的肾移植受者的皮肤不良事件。
Transplantation. 2005 Feb 27;79(4):476-82. doi: 10.1097/01.tp.0000151630.25127.3a.
10
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies.西罗莫司治疗复杂血管异常的疗效与安全性。
Pediatrics. 2016 Feb;137(2):e20153257. doi: 10.1542/peds.2015-3257. Epub 2016 Jan 18.
引用本文的文献
1
Optimal GVHD Prophylaxis.最佳移植物抗宿主病预防措施
Adv Exp Med Biol. 2025;1475:77-102. doi: 10.1007/978-3-031-84988-6_5.
2
Epilepsy in the mTORopathies: opportunities for precision medicine.mTOR 病中的癫痫：精准医学的机遇
Brain Commun. 2021 Sep 25;3(4):fcab222. doi: 10.1093/braincomms/fcab222. eCollection 2021.
Zotero 插件